Treatment of chronic pyelonephritis with urovalidin.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D002908:Chronic Disease; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000627:therapeutic use*; D010621:Phenazopyridine / Q000627:therapeutic use; D011704:Pyelonephritis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D011725:Pyridines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D004338:Drug Combinations; D010080:Oxazoles; D011725:Pyridines; D010621:Phenazopyridine